{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:31:15Z","timestamp":1790886675436,"version":"4.1.0"},"reference-count":86,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T00:00:00Z","timestamp":1732924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Bornstein Research Fund"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>CXCL13 is a chemokine which is upregulated within the CNS in multiple sclerosis, Lyme neuroborreliosis, and other inflammatory diseases and is increasingly clinically useful as a biomarker. This review provides background for understanding its function in the immune system and its relationship to ectopic lymphoid follicles. Also reviewed are its utility in multiple sclerosis and Lyme neuroborreliosis and potential problems in its measurement. CXCL13 has the potential to be an exceptionally useful biomarker in a range of inflammatory diseases.<\/jats:p>","DOI":"10.3390\/biom14121541","type":"journal-article","created":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T06:58:58Z","timestamp":1733122738000},"page":"1541","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["CXCL13 as a Biomarker: Background and Utility in Multiple Sclerosis"],"prefix":"10.3390","volume":"14","author":[{"given":"Andrew R.","family":"Pachner","sequence":"first","affiliation":[{"name":"Geisel School of Medicine at Dartmouth, Dartmouth-Hitchcock Medical Center, Lebanon, NH 03756, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6990-6861","authenticated-orcid":false,"given":"Steven","family":"Pike","sequence":"additional","affiliation":[{"name":"Geisel School of Medicine at Dartmouth, Dartmouth-Hitchcock Medical Center, Lebanon, NH 03756, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew D.","family":"Smith","sequence":"additional","affiliation":[{"name":"Geisel School of Medicine at Dartmouth, Dartmouth-Hitchcock Medical Center, Lebanon, NH 03756, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Gilli","sequence":"additional","affiliation":[{"name":"Geisel School of Medicine at Dartmouth, Dartmouth-Hitchcock Medical Center, Lebanon, NH 03756, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,11,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/35876","article-title":"A B-cell-homing chemokine made in lymphoid follicles activates Burkitt\u2019s lymphoma receptor-1","volume":"391","author":"Gunn","year":"1998","journal-title":"Nature"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1084\/jem.187.4.655","article-title":"B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1\/CXCR5","volume":"187","author":"Legler","year":"1998","journal-title":"J. Exp. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0092-8674(00)81798-5","article-title":"A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen","volume":"87","author":"Forster","year":"1996","journal-title":"Cell"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1084\/jem.194.1.45","article-title":"A coordinated change in chemokine responsiveness guides plasma cell movements","volume":"194","author":"Hargreaves","year":"2001","journal-title":"J. Exp. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1002\/ana.20486","article-title":"The nervous system as ectopic germinal center: CXCL13 and IgG in lyme neuroborreliosis","volume":"57","author":"Narayan","year":"2005","journal-title":"Ann. Neurol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jneuroim.2003.10.056","article-title":"Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis","volume":"148","author":"Magliozzi","year":"2004","journal-title":"J. Neuroimmunol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1093\/brain\/awm038","article-title":"Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology","volume":"130","author":"Magliozzi","year":"2007","journal-title":"Brain"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1093\/brain\/awh680","article-title":"Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment","volume":"129","author":"Krumbholz","year":"2006","journal-title":"Brain"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.clim.2018.08.003","article-title":"Induction of plasmablasts by follicular helper T cell-CXCL13 axis upon occurrence of herpes zoster","volume":"195","author":"Fukuchi","year":"2018","journal-title":"Clin. Immunol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.4049\/jimmunol.1103246","article-title":"Bcl6 and Maf cooperate to instruct human follicular helper CD4 T cell differentiation","volume":"188","author":"Kroenke","year":"2012","journal-title":"J. Immunol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/1742-2094-9-93","article-title":"CXCL13 is the major determinant for B cell recruitment to the CSF during neuroinflammation","volume":"9","author":"Kowarik","year":"2012","journal-title":"J. Neuroinflamm."},{"key":"ref_12","first-page":"e139","article-title":"Role of T Follicular Helper cells in Multiple Sclerosis","volume":"1","author":"Schmitt","year":"2015","journal-title":"J. Nat. Sci."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Cunill, V., Massot, M., Clemente, A., Calles, C., Andreu, V., N\u00fa\u00f1ez, V., L\u00f3pez-G\u00f3mez, A., D\u00edaz, R.M., Jim\u00e9nez, M.L.R., and Pons, J. (2018). Relapsing-Remitting Multiple Sclerosis Is Characterized by a T Follicular Cell Pro-Inflammatory Shift, Reverted by Dimethyl Fumarate Treatment. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.01097"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Quinn, J.L., and Axtell, R.C. (2018). Emerging Role of Follicular T Helper Cells in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis. Int. J. Mol. Sci., 19.","DOI":"10.20944\/preprints201810.0031.v1"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"110262","DOI":"10.1016\/j.clim.2024.110262","article-title":"Effects of anti-CD20 therapy on circulating and intrathecal follicular helper T cell subsets in multiple sclerosis","volume":"264","author":"Hansen","year":"2024","journal-title":"Clin. Immunol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e200009","DOI":"10.1212\/NXI.0000000000200009","article-title":"Increased Intrathecal Activity of Follicular Helper T Cells in Patients With Relapsing-Remitting Multiple Sclerosis","volume":"9","author":"Talbot","year":"2022","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1093\/brain\/awq223","article-title":"Detection of Epstein-Barr virus and B-cell follicles in the multiple sclerosis brain: What you find depends on how and where you look","volume":"133","author":"Aloisi","year":"2010","journal-title":"Brain"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/imm.13395","article-title":"Ectopic lymphoid follicles in progressive multiple sclerosis: From patients to animal models","volume":"164","author":"Zhan","year":"2021","journal-title":"Immunology"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Negron, A., Stuve, O., and Forsthuber, T.G. (2020). Ectopic Lymphoid Follicles in Multiple Sclerosis: Centers for Disease Control?. Front. Neurol., 11.","DOI":"10.3389\/fneur.2020.607766"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Pikor, N.B., Prat, A., Bar-Or, A., and Gommerman, J.L. (2015). Meningeal Tertiary Lymphoid Tissues and Multiple Sclerosis: A Gathering Place for Diverse Types of Immune Cells during CNS Autoimmunity. Front. Immunol., 6.","DOI":"10.3389\/fimmu.2015.00657"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Kee, R., Naughton, M., McDonnell, G.V., Howell, O.W., and Fitzgerald, D.C. (2022). A Review of Compartmentalised Inflammation and Tertiary Lymphoid Structures in the Pathophysiology of Multiple Sclerosis. Biomedicines, 10.","DOI":"10.3390\/biomedicines10102604"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1172\/JCI71611","article-title":"Lymphatic vessels and tertiary lymphoid organs","volume":"124","author":"Ruddle","year":"2014","journal-title":"J. Clin. Investig."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e1012","DOI":"10.1212\/NXI.0000000000001012","article-title":"Anti-CD20 Depletes Meningeal B Cells but Does Not Halt the Formation of Meningeal Ectopic Lymphoid Tissue","volume":"8","author":"Brand","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e200185","DOI":"10.1212\/NXI.0000000000200185","article-title":"Single-Cell Profiling Indicates a Proinflammatory Role of Meningeal Ectopic Lymphoid Tissue in Experimental Autoimmune Encephalomyelitis","volume":"11","author":"Diddens","year":"2024","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e1117","DOI":"10.1212\/NXI.0000000000001117","article-title":"Siponimod Inhibits the Formation of Meningeal Ectopic Lymphoid Tissue in Experimental Autoimmune Encephalomyelitis","volume":"9","author":"Brand","year":"2022","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s00401-012-1023-3","article-title":"Tertiary lymphoid organ development coincides with determinant spreading of the myelin-specific T cell response","volume":"124","author":"Kuerten","year":"2012","journal-title":"Acta Neuropathol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jneuroim.2006.06.015","article-title":"Suppression of established experimental autoimmune encephalomyelitis and formation of meningeal lymphoid follicles by lymphotoxin beta receptor-Ig fusion protein","volume":"179","author":"Griguoli","year":"2006","journal-title":"J. Neuroimmunol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1128\/iai.11.5.1147-1155.1975","article-title":"Theiler\u2019s virus infection in mice: An unusual biphasic disease process leading to demyelination","volume":"11","author":"Lipton","year":"1975","journal-title":"Infect. Immun."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nm0298-187","article-title":"Absence of neurological deficits following extensive demyelination in a class I-deficient murine model of multiple sclerosis","volume":"4","author":"McGavern","year":"1998","journal-title":"Nat. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1128\/CMR.17.1.174-207.2004","article-title":"Theiler\u2019s virus infection: A model for multiple sclerosis","volume":"17","author":"Oleszak","year":"2004","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jneuroim.2007.09.001","article-title":"Antibody-secreting cells in the central nervous system in an animal model of MS: Phenotype, association with disability, and in vitro production of antibody","volume":"190","author":"Pachner","year":"2007","journal-title":"J. Neuroimmunol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jneuroim.2007.01.017","article-title":"Intrathecal antibody production in an animal model of multiple sclerosis","volume":"185","author":"Pachner","year":"2007","journal-title":"J. Neuroimmunol."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"DiSano, K.D., Royce, D.B., Gilli, F., and Pachner, A.R. (2019). Central Nervous System Inflammatory Aggregates in the Theiler\u2019s Virus Model of Progressive Multiple Sclerosis. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.01821"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.bbi.2016.01.016","article-title":"CXCL13 promotes isotype-switched B cell accumulation to the central nervous system during viral encephalomyelitis","volume":"54","author":"Phares","year":"2016","journal-title":"Brain Behav. Immun."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.1128\/JVI.03307-12","article-title":"Astrocyte-derived CXCL10 drives accumulation of antibody-secreting cells in the central nervous system during viral encephalomyelitis","volume":"87","author":"Phares","year":"2013","journal-title":"J. Virol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1126\/science.424741","article-title":"Multiple sclerosis: Presence of lymphatic capillaries and lymphoid tissue in the brain and spinal cord","volume":"203","author":"Prineas","year":"1979","journal-title":"Science"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1750-3639.2004.tb00049.x","article-title":"Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis","volume":"14","author":"Serafini","year":"2004","journal-title":"Brain Pathol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jneuroim.2008.04.025","article-title":"Lymphoid chemokines in chronic neuroinflammation","volume":"198","author":"Aloisi","year":"2008","journal-title":"J. Neuroimmunol."},{"key":"ref_39","first-page":"e87234","article-title":"B cell repertoire expansion occurs in meningeal ectopic lymphoid tissue","volume":"1","author":"Wang","year":"2016","journal-title":"JCI Insight"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"11064","DOI":"10.1073\/pnas.0402455101","article-title":"Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis","volume":"101","author":"Corcione","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1093\/brain\/awr182","article-title":"Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis","volume":"134","author":"Howell","year":"2011","journal-title":"Brain"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1097\/NEN.0b013e3181b4bf8f","article-title":"Meningeal inflammation is not associated with cortical demyelination in chronic multiple sclerosis","volume":"68","author":"Kooi","year":"2009","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1093\/brain\/awp296","article-title":"Epstein Barr virus is not a characteristic feature in the central nervous system in established multiple sclerosis","volume":"133","author":"Peferoen","year":"2010","journal-title":"Brain"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/j.1750-3639.2009.00343.x","article-title":"Upregulation of immunoglobulin-related genes in cortical sections from multiple sclerosis patients","volume":"20","author":"Torkildsen","year":"2010","journal-title":"Brain Pathol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1056\/NEJMoa1100648","article-title":"Inflammatory cortical demyelination in early multiple sclerosis","volume":"365","author":"Lucchinetti","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_46","first-page":"99","article-title":"Cerebrospinal fluid\u2014Physiology, analysis and interpretation of protein patterns for diagnosis of neurological diseases","volume":"4","author":"Reiber","year":"1998","journal-title":"Mult. Scler."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12987-020-0170-5","article-title":"Chemokine CXCL13 in serum, CSF and blood-CSF barrier function: Evidence of compartment restriction","volume":"17","author":"Pilz","year":"2020","journal-title":"Fluids Barriers CNS"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12987-021-00244-5","article-title":"Are CSF CXCL13 concentrations solely dependent on intrathecal production? A commentary on \u201cChemokine CXCL13 in serum, CSF, and blood-CSF barrier function\u201d","volume":"18","author":"DiSano","year":"2021","journal-title":"Fluids Barriers CNS"},{"key":"ref_49","first-page":"296184","article-title":"Intrathecal IgG synthesis: A resistant and valuable target for future multiple sclerosis treatments","volume":"2015","author":"Bonnan","year":"2015","journal-title":"Mult. Scler. Int."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1006\/cyto.2002.1973","article-title":"Increased expression of B-lymphocyte chemoattractant, but not pro-inflammatory cytokines, in muscle tissue in rhesus chronic Lyme borreliosis","volume":"19","author":"Pachner","year":"2002","journal-title":"Cytokine"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1128\/JCM.00084-11","article-title":"Discriminating Lyme neuroborreliosis from other neuroinflammatory diseases by levels of CXCL13 in cerebrospinal fluid","volume":"49","author":"Bakels","year":"2011","journal-title":"J. Clin. Microbiol."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"van Gorkom, T., van Arkel, G.H.J., Heron, M., Voet, W., Thijsen, S.F.T., and Kremer, K. (2021). The Usefulness of Two CXCL13 Assays on Cerebrospinal Fluid for the Diagnosis of Lyme Neuroborreliosis: A Retrospective Study in a Routine Clinical Setting. J. Clin. Microbiol., 59.","DOI":"10.1128\/JCM.00255-21"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"11795735241247026","DOI":"10.1177\/11795735241247026","article-title":"CXCL13 as a biomarker in the diagnostics of European lyme Neuroborreliosis\u2014A prospective multicentre study in Austria","volume":"16","author":"Graichen","year":"2024","journal-title":"J. Cent. Nerv. Syst. Dis."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1212\/WNL.0b013e3181c5b457","article-title":"Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS","volume":"73","author":"Sellebjerg","year":"2009","journal-title":"Neurology"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Brettschneider, J., Czerwoniak, A., Senel, M., Fang, L., Kassubek, J., Pinkhardt, E., Lauda, F., Kapfer, T., Jesse, S., and Lehmensiek, V. (2010). The chemokine CXCL13 is a prognostic marker in clinically isolated syndrome (CIS). PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0011986"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1177\/1352458510389102","article-title":"Cerebrospinal fluid CXCL13 in multiple sclerosis: A suggestive prognostic marker for the disease course","volume":"17","author":"Khademi","year":"2011","journal-title":"Multiple Scler."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"102463","DOI":"10.1016\/j.msard.2020.102463","article-title":"NFL and CXCL13 may reveal disease activity in clinically and radiologically stable MS","volume":"46","author":"Novakova","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s12035-022-03060-6","article-title":"CSF CXCL13 and Chitinase 3-like-1 Levels Predict Disease Course in Relapsing Multiple Sclerosis","volume":"60","author":"Lucchini","year":"2023","journal-title":"Mol. Neurobiol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"e520","DOI":"10.1212\/NXI.0000000000000520","article-title":"Clinical utility of a molecular signature in inflammatory demyelinating disease","volume":"6","author":"Pachner","year":"2019","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"ref_60","first-page":"2055217320981396","article-title":"Intrathecally produced CXCL13: A predictive biomarker in multiple sclerosis","volume":"6","author":"DiSano","year":"2020","journal-title":"Mult. Scler. J. Exp. Transl. Clin."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Pike, S.C., Gilli, F., and Pachner, A.R. (2023). The CXCL13 Index as a Predictive Biomarker for Activity in Clinically Isolated Syndrome. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241311050"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Pachner, A., Pike, S., Smith, A.D., and Gilli, F. (2024). The CXCL13 index biomarker predicts success or failure of moderate-efficacy disease-modifying therapies in multiple sclerosis; a real-world study, submitted.","DOI":"10.2139\/ssrn.4916049"},{"key":"ref_63","first-page":"2055217315623800","article-title":"Predicting optimal response to B-cell depletion with rituximab in multiple sclerosis using CXCL13 index, magnetic resonance imaging and clinical measures","volume":"1","author":"Alvarez","year":"2015","journal-title":"Mult. Scler. J. Exp. Transl. Clin."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"e200050","DOI":"10.1212\/NXI.0000000000200050","article-title":"Serum Levels of CXCL13 Are Associated with Teriflunomide Response in Patients with Multiple Sclerosis","volume":"10","author":"Fissolo","year":"2023","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1182\/blood-2002-05-1576","article-title":"Expression of B-cell-attracting chemokine 1 (CXCL13) by malignant lymphocytes and vascular endothelium in primary central nervous system lymphoma","volume":"101","author":"Smith","year":"2003","journal-title":"Blood"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"5968","DOI":"10.1158\/1078-0432.CCR-09-0108","article-title":"CXCL13 and CXCL12 in central nervous system lymphoma patients","volume":"15","author":"Fischer","year":"2009","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1007\/s00277-023-05560-4","article-title":"Role and application of chemokine CXCL13 in central nervous system lymphoma","volume":"103","author":"Li","year":"2024","journal-title":"Ann. Hematol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1002\/art.39315","article-title":"CXCL13 and CCL11 Serum Levels and Lymphoma and Disease Activity in Primary Sjogren\u2019s Syndrome","volume":"67","author":"Nocturne","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"131","DOI":"10.55563\/clinexprheumatol\/fp741f","article-title":"Serum CXCL13, BAFF, IL-21 and IL-22 levels are related to disease activity and lymphocyte profile in primary Sjogren\u2019s syndrome","volume":"39","author":"Palacio","year":"2021","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"e8675","DOI":"10.1097\/MD.0000000000008675","article-title":"The correlational research among serum CXCL13 levels, circulating plasmablasts and memory B cells in patients with systemic lupus erythematosus: A STROBE-compliant article","volume":"96","author":"Fang","year":"2017","journal-title":"Medicine"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s10238-021-00707-x","article-title":"The CXCL13 chemokine serves as a potential biomarker to diagnose systemic lupus erythematosus with disease activity","volume":"21","author":"Zeng","year":"2021","journal-title":"Clin. Exp. Med."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1001\/jamaneurol.2014.2956","article-title":"Investigations on CXCL13 in anti-N-methyl-D-aspartate receptor encephalitis: A potential biomarker of treatment response","volume":"72","author":"Leypoldt","year":"2015","journal-title":"JAMA Neurol."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Erhart, D.K., Klose, V., Schaper, T., Tumani, H., and Senel, M. (2023). CXCL13 in Cerebrospinal Fluid: Clinical Value in a Large Cross-Sectional Study. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25010425"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1212\/WNL.0b013e318211c39a","article-title":"A prospective study on the role of CXCL13 in Lyme neuroborreliosis","volume":"76","author":"Schmidt","year":"2011","journal-title":"Neurology"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1158\/1055-9965.EPI-21-0509","article-title":"Intraindividual Long-term Immune Marker Stability in Plasma Samples Collected in Median 9.4 Years Apart in 304 Adult Cancer-free Individuals","volume":"30","author":"Spath","year":"2021","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/0019-2791(71)90454-X","article-title":"Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulin G","volume":"8","author":"Engvall","year":"1971","journal-title":"Immunochemistry"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"e00207-20","DOI":"10.1128\/JCM.00207-20","article-title":"Comparative Analysis of the Euroimmun CXCL13 Enzyme-Linked Immunosorbent Assay and the ReaScan Lateral Flow Immunoassay for Diagnosis of Lyme Neuroborreliosis","volume":"58","author":"Ziegler","year":"2020","journal-title":"J. Clin. Microbiol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.diagmicrobio.2018.02.013","article-title":"Point-of-care testing for CXCL13 in Lyme neuroborreliosis","volume":"91","author":"Pietikainen","year":"2018","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"116725","DOI":"10.1016\/j.trac.2022.116725","article-title":"Lateral flow assays for viruses diagnosis: Up-to-date technology and future prospects","volume":"157","author":"Ince","year":"2022","journal-title":"Trends Analyt. Chem."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"102281","DOI":"10.1016\/j.msard.2020.102281","article-title":"Highly sensitive quantification of optic neuritis intrathecal biomarker CXCL13","volume":"44","author":"Olesen","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/1742-2094-11-103","article-title":"CXCL13 and neopterin concentrations in cerebrospinal fluid of patients with Lyme neuroborreliosis and other diseases that cause neuroinflammation","volume":"11","author":"Hytonen","year":"2014","journal-title":"J. Neuroinflamm."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12974-019-1440-5","article-title":"Cerebrospinal fluid biomarkers for predicting development of multiple sclerosis in acute optic neuritis: A population-based prospective cohort study","volume":"16","author":"Olesen","year":"2019","journal-title":"J. Neuroinflamm."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"6903","DOI":"10.1038\/s41467-023-42682-9","article-title":"Proteomics reveal biomarkers for diagnosis, disease activity and long-term disability outcomes in multiple sclerosis","volume":"14","author":"Hojjati","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/apm.12596","article-title":"Evaluation of two assays for CXCL13 analysis in cerebrospinal fluid for laboratory diagnosis of Lyme neuroborreliosis","volume":"124","author":"Henningsson","year":"2016","journal-title":"APMIS"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.ttbdis.2018.04.008","article-title":"CXCL13 concentrations in cerebrospinal fluid of patients with Lyme neuroborreliosis and other neurological disorders determined by Luminex and ELISA","volume":"9","author":"Markowicz","year":"2018","journal-title":"Ticks Tick Borne Dis."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jim.2007.09.011","article-title":"Effect of serum content and diluent selection on assay sensitivity and signal intensity in multiplex bead-based immunoassays","volume":"329","author":"Pfleger","year":"2008","journal-title":"J. Immunol. Methods"}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/14\/12\/1541\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:43:55Z","timestamp":1760114635000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/14\/12\/1541"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,30]]},"references-count":86,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["biom14121541"],"URL":"https:\/\/doi.org\/10.3390\/biom14121541","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,30]]}}}